A Rheumatology-Specific Informatics-Based Application With a Disease Activity Calculator

被引:12
作者
Collier, Deborah S. [1 ,2 ]
Kay, Jonathan [2 ]
Estey, Greg
Surrao, Dominic
Chueh, Henry C. [2 ]
Grant, Richard W. [2 ]
机构
[1] Massachusetts Gen Hosp, Yawkey Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2009年 / 61卷 / 04期
关键词
ARTHRITIS; VALIDATION; OUTCOMES; STRATEGY;
D O I
10.1002/art.24345
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective. To design a rheumatology-specific tool with a disease activity calculator integrated into the electronic medical records (EMRs) at our institution and assess physicians' attitudes toward the use of this tool. Methods. The Rheumatology OnCall (ROC) application culls rheumatology-pertinent data from our institution's laboratory, microbiology, pathology, radiology, and pharmacy information systems. Attending rheumatologists and rheumatology fellows accessed the ROC and disease activity calculator during outpatient visits at the time of the clinical encounter. Results. During the 12-week study period, 15 physicians used the ROC application and the disease activity calculator during 474 and 429 outpatient clinic visits, respectively. In weekly survey responses, physicians reported that use of the ROC interface improved patient care in 140 (78%) of 179 visits, and that the Disease Activity Score in 28 joints (DAS28) results at the time of the visit would not have changed patient management in 157 (88%) of these, although seeing a trend in DAS28 was useful in 149 (96%) of 156 visits. At the study's conclusion, most physicians reported that the ROC application was useful (11 of 12 physicians) and that seeing a trend in DAS28 improved daily patient care (12 of 13 physicians). Conclusion. The ROC application is useful in daily rheumatologic care, and the disease activity calculator facilitates management of patients with rheumatoid arthritis. However, widespread acceptance and use of such tools depend upon the general acceptance of and access to EMRs in the clinical setting. The utility of the disease activity calculator may be limited by the lack of available acute-phase reactant results at the time of the clinical encounter.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 15 条
[1]
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score [J].
Aletaha, D ;
Nell, VP ;
Stamm, T ;
Uffmann, M ;
Pflugbeil, S ;
Machold, K ;
Smolen, JS .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) :R796-R806
[2]
*AM COLL RHEUM, QUAL MEAS
[3]
ANDERSON MR, AM COLL RHEUMATOLOGY
[4]
BELLAMY N, 1988, J RHEUMATOL, V15, P1833
[5]
DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[6]
The United States rheumatology workforce - Supply and demand, 2005-2025 [J].
Deal, Chad L. ;
Hooker, Roderick ;
Harrington, Timothy ;
Birnbaum, Neal ;
Hogan, Paul ;
Bouchery, Ellen ;
Klein-Gitelman, Marisa ;
Barr, Walter .
ARTHRITIS AND RHEUMATISM, 2007, 56 (03) :722-729
[7]
Electronic health records in ambulatory care - A national survey of physicians [J].
DesRoches, Catherine M. ;
Campbell, Eric G. ;
Rao, Sowmya R. ;
Donelan, Karen ;
Ferris, Timothy G. ;
Jha, Ashish ;
Kaushal, Rainu ;
Levy, Douglas E. ;
Rosenbaum, Sara ;
Shields, Alexandra E. ;
Blumenthal, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01) :50-60
[8]
Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[9]
A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis [J].
Gardiner, PV ;
Bell, AL ;
Taggart, AJ ;
Wright, G ;
Kee, F ;
Smyth, A ;
McKane, R ;
Lee, J ;
Rooney, ME ;
Whitehead, E .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) :506-507
[10]
GARRETT S, 1994, J RHEUMATOL, V21, P2286